John V. Oyler

John V. Oyler, MBA - President and CEO, BioDuro, Inc.

"John Oyler is a serial entrepreneur with a track record of success who has started and managed numerous companies and raised over $US225 million in capital. During his career, Mr. Oyler has been responsible for a wide array of activities including: organization building, partnering with multi-national companies, instigating clinical trials at Sloan Kettering, Sidney Kimmel, and Mass General, licensing and managing intellectual property, building software-database-statistical capabilities to handle extremely large-scale data, and most importantly building highly functional, world-class organizations. In the biotech field John started (or re-started, in the case of Genta) 4 companies: Galenea (private), Genta (Nasdaq - GNTA; co-CEO), Walden Laboratories (merged into Indeveus - IDEV, VP of Operations), Oasis Biosciences (sold to Genprobe -GPRO). Outside of the biotech field John has been involved in starting 4 companies: Telephia (private, profitable, growing; founder and manager), Verdisoft (sold with attractive returns to Yahoo, General Manager). RTI (Founder and manager). In addition, Mr. Oyler was involved for several years in performance improvement and strategic growth initiatives at McKinsey & Co., the international consulting firm where he spent 1992-3 working in China."

"Bioduro’s co-founders, John Oyler, who has founded and run several biotech companies, including the Cambridge-based Galenea Corp".